Jeff Bezos Funds an Anti-Aging Study

Jeff Bezos Funds an Anti-Aging Study

Did you know that Jeff Bezos is funding an anti-aging study? This article is a must-read! Will this be our future? Keep reading to find out. 

Did you know that Jeff Bezos is funding an anti-aging study? This article is a must-read! Will this be our future? Keep reading to find out. 

Amazon and Blue Origin founder Jeff Bezos and Yuri Milner, a Russian-Israeli billionaire investor in science and technology projects, appear to have joined forces to fund research at Altos Labs, a biotech startup seeking to extend human life. 

Amazon and Blue Origin founder Jeff Bezos and Yuri Milner, a Russian-Israeli billionaire investor in science and technology projects

Founded earlier this year, the Silicon Valley company plans to establish several institutes in places like the United States, the United Kingdom, and Japan; and to that end it is recruiting a large group of scientists "with splendid salaries" and the promise that they can carry out "unrestricted research" on how cells age and how to reverse that process, details the MIT Technology Review.

Among the great minds whose names resonate to join, the MIT portal names Juan Carlos Izpisúa Belmonte, a Spanish biologist from the Salk Institute who gained notoriety for research on human and monkey embryos and who assured that the life expectancy of the humans could extend 50 years.

The company, they explain, would focus on studying cell reprogramming

Steve Horvath, professor at the University of California and developer of a "biological clock" that can accurately measure human aging, and Shinya Yamanaka, winner of the Nobel Prize for his research on the reversal of aging in cells who confirmed his role as chairman of the scientific advisory council of Altos Labs stating that "Although there are many obstacles to overcome, there is enormous potential."

The company, they explain, would focus on studying cell reprogramming, a technique that earned Yamanaka the Nobel Prize in Medicine in 2012 and with which, by adding only four proteins - now known as Yamanaka factors - cells can receive instructions for returning to a primitive state with the properties of embryonic stem cells. And also a technique that, in 2016, the Izpisúa Belmonte laboratory had applied to live mice, achieving signs of reversion of age.

Some scientists, however, are skeptical of this scenario and claim that the concept is sound (the technique has an indisputable and repeatable effect in laboratory experiments when applied to individual cells) but there is a lot of publicity; at the same time that it is too risky to try and far from being human therapy.

Related Articles

More News

More News